[{"address1": "18702 North Creek Parkway", "address2": "Suite 100", "city": "Bothell", "state": "WA", "zip": "98011", "country": "United States", "phone": "425 939 7410", "website": "https://immunome.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Immunome, Inc., a clinical-stage biotechnology company, develops targeted cancer therapies. The company's clinical asset comprises Varegacestat, a gamma secretase inhibitor that is in Phase 3 clinical trial for the treatment of desmoid tumors; and IM-1021, a receptor tyrosine kinase-like orphan receptor 1 antibody-drug conjugate (ADC), which is in Phase 1 clinical trial. Its preclinical assets include IM-3050, a fibroblast activation protein targeted radioligand therapy; and solid tumor ADC drug candidates, including IM-1617, IM-1340, and IM-1335. Immunome, Inc. was incorporated in 2006 and is based in Bothell, Washington.", "fullTimeEmployees": 168, "companyOfficers": [{"maxAge": 1, "name": "Dr. Clay B. Siegall Ph.D.", "age": 63, "title": "Chairman, President & CEO", "yearBorn": 1961, "fiscalYear": 2024, "totalPay": 1235350, "exercisedValue": 0, "unexercisedValue": 15820780}, {"maxAge": 1, "name": "Ms. Sandra G. Stoneman Esq., J.D.", "age": 51, "title": "Chief Legal Officer, General Counsel & Corporate Secretary", "yearBorn": 1973, "fiscalYear": 2024, "totalPay": 715350, "exercisedValue": 0, "unexercisedValue": 341880}, {"maxAge": 1, "name": "Mr. Kinney  Horn", "age": 49, "title": "Chief Business Officer", "yearBorn": 1975, "fiscalYear": 2024, "totalPay": 598862, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Max  Rosett", "age": 34, "title": "Chief Financial Officer", "yearBorn": 1990, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Philip  Tsai", "title": "Chief Technical Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Jack  Higgins Ph.D.", "age": 44, "title": "Chief Scientific Officer", "yearBorn": 1980, "fiscalYear": 2024, "totalPay": 956342, "exercisedValue": 0, "unexercisedValue": 734891}, {"maxAge": 1, "name": "Dr. Robert J. Lechleider M.D.", "age": 62, "title": "Chief Medical Officer", "yearBorn": 1962, "fiscalYear": 2024, "totalPay": 512488, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Roee  Shahar", "title": "Executive Vice President of Commercial", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 7, "boardRisk": 9, "compensationRisk": 10, "shareHolderRightsRisk": 7, "overallRisk": 10, "governanceEpochDate": 1761955200, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 17.51, "open": 17.46, "dayLow": 17.3, "dayHigh": 19.0145, "regularMarketPreviousClose": 17.51, "regularMarketOpen": 17.46, "regularMarketDayLow": 17.3, "regularMarketDayHigh": 19.0145, "payoutRatio": 0.0, "beta": 2.191, "forwardPE": -6.389655, "volume": 1409540, "regularMarketVolume": 1409540, "averageVolume": 1480547, "averageVolume10days": 1553240, "averageDailyVolume10Day": 1553240, "bid": 13.48, "ask": 22.38, "bidSize": 2, "askSize": 2, "marketCap": 1699391488, "fiftyTwoWeekLow": 5.15, "fiftyTwoWeekHigh": 19.0145, "allTimeHigh": 63.78, "allTimeLow": 2.09, "priceToSalesTrailing12Months": 175.5751, "fiftyDayAverage": 14.2201, "twoHundredDayAverage": 10.306375, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 1430765440, "profitMargins": 0.0, "floatShares": 75173997, "sharesOutstanding": 91710277, "sharesShort": 15092876, "sharesShortPriorMonth": 15469351, "sharesShortPreviousMonthDate": 1759190400, "dateShortInterest": 1761868800, "sharesPercentSharesOut": 0.16459998, "heldPercentInsiders": 0.094510004, "heldPercentInstitutions": 0.98708, "shortRatio": 11.85, "shortPercentOfFloat": 0.1715, "impliedSharesOutstanding": 91710277, "bookValue": 2.878, "priceToBook": 6.438499, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -222743008, "trailingEps": -2.96, "forwardEps": -2.9, "enterpriseToRevenue": 147.822, "enterpriseToEbitda": -6.994, "52WeekChange": 0.5704036, "SandP52WeekChange": 0.09209216, "quoteType": "EQUITY", "currentPrice": 18.53, "targetHighPrice": 38.0, "targetLowPrice": 18.0, "targetMeanPrice": 24.72727, "targetMedianPrice": 22.0, "recommendationMean": 1.16667, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 11, "totalCash": 272639008, "totalCashPerShare": 2.973, "ebitda": -204563008, "totalDebt": 4013000, "quickRatio": 8.67, "currentRatio": 8.902, "totalRevenue": 9679000, "debtToEquity": 1.521, "revenuePerShare": 0.122, "returnOnAssets": -0.46480998, "returnOnEquity": -0.93037003, "grossProfits": -164727008, "freeCashflow": -127748248, "operatingCashflow": -185026000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": -21.37101, "financialCurrency": "USD", "symbol": "IMNM", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "Immunome, Inc.", "longName": "Immunome, Inc.", "corporateActions": [], "postMarketTime": 1763770501, "regularMarketTime": 1763758802, "exchange": "NCM", "messageBoardId": "finmb_108518404", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": 5.82525, "regularMarketPrice": 18.53, "marketState": "CLOSED", "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -2.96, "epsForward": -2.9, "epsCurrentYear": -2.21, "priceEpsCurrentYear": -8.384616, "fiftyDayAverageChange": 4.3099003, "fiftyDayAverageChangePercent": 0.3030851, "twoHundredDayAverageChange": 8.223626, "twoHundredDayAverageChangePercent": 0.7979165, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2020-10-02", "averageAnalystRating": "1.2 - Strong Buy", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1601645400000, "postMarketChangePercent": 1.9427884, "postMarketPrice": 18.89, "postMarketChange": 0.3599987, "regularMarketChange": 1.02, "regularMarketDayRange": "17.3 - 19.0145", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 1480547, "fiftyTwoWeekLowChange": 13.380001, "fiftyTwoWeekLowChangePercent": 2.5980585, "fiftyTwoWeekRange": "5.15 - 19.0145", "fiftyTwoWeekHighChange": -0.48449898, "fiftyTwoWeekHighChangePercent": -0.025480501, "fiftyTwoWeekChangePercent": 57.04036, "earningsTimestamp": 1762462800, "earningsTimestampStart": 1762462800, "earningsTimestampEnd": 1762462800, "displayName": "Immunome", "trailingPegRatio": null, "__fetch_time": "2025-11-22"}]